Waters Corporation $WAT Stake Boosted by Logan Capital Management Inc.

Posted by Francis Steltz on Jun 12th, 2026

Logan Capital Management Inc. increased its position in shares of Waters Corporation (NYSE:WAT – Free Report) by 7.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 37,790 shares of the medical instruments supplier’s stock after buying an additional 2,502 shares during the quarter. Logan Capital Management Inc.’s holdings in Waters were worth $14,354,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of WAT. Zions Bancorporation National Association UT grew its stake in Waters by 121.2% in the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock valued at $28,000 after purchasing an additional 40 shares in the last quarter. ANTIPODES PARTNERS Ltd acquired a new stake in shares of Waters during the 3rd quarter valued at about $26,000. Hantz Financial Services Inc. grew its stake in shares of Waters by 115.4% in the 3rd quarter. Hantz Financial Services Inc. now owns 112 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 60 shares in the last quarter. eCIO Inc. bought a new stake in shares of Waters in the 4th quarter valued at approximately $49,000. Finally, Annis Gardner Whiting Capital Advisors LLC increased its holdings in Waters by 28.3% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 163 shares of the medical instruments supplier’s stock worth $62,000 after buying an additional 36 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Insider Buying and Selling at Waters

In other Waters news, Director Wei Jiang bought 500 shares of the firm’s stock in a transaction that occurred on Monday, March 16th. The stock was purchased at an average price of $289.46 per share, for a total transaction of $144,730.00. Following the purchase, the director directly owned 3,441 shares in the company, valued at $996,031.86. This trade represents a 17.00% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.31% of the company’s stock.

Waters Price Performance

NYSE WAT opened at $359.80 on Friday. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $414.15. The company has a fifty day simple moving average of $336.59 and a 200 day simple moving average of $350.23. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32. The company has a market cap of $35.33 billion, a P/E ratio of 45.72, a P/E/G ratio of 2.20 and a beta of 1.21.

Waters (NYSE:WAT – Get Free Report) last announced its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, topping the consensus estimate of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The firm had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.20 billion. During the same quarter last year, the firm posted $2.25 EPS. The business’s quarterly revenue was up 91.4% on a year-over-year basis. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, sell-side analysts predict that Waters Corporation will post 14.5 EPS for the current year.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Bank of America lifted their target price on shares of Waters from $370.00 to $400.00 and gave the company a “neutral” rating in a research note on Tuesday, June 2nd. Piper Sandler initiated coverage on shares of Waters in a report on Thursday. They set a “neutral” rating and a $400.00 price target on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a report on Monday, April 20th. TD Cowen increased their target price on shares of Waters from $345.00 to $385.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. raised their target price on Waters from $330.00 to $345.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Three investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $394.56.

Read Our Latest Analysis on WAT

Waters Company Profile

(Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.